How LivBio began

Our founder Takashi supported a number of clients enter and succeed in the European and Japanese healthcare markets. Since then, he led the European market entry of a Japanese pharmaceutical as its first European CEO.

‘Europe is the second largest healthcare market in the world.’ ‘Although the market appears complicated, if a company can build an insider position with strong local staff, it can succeed.’ This is Takashi’s conviction. As for Japan, it is the forth largest healthcare market and more and more non-Japanese companies are successfully building business there.

Takashi and his team set up LivBio to support companies with innovative products and technologies to find their feet in Europe and Japan, succeed, and, in doing so, improve the lives of patients.